Form 4: Gilead Sciences SVP, Controllership Sandra Patterson Reports Stock Transactions

Sandra Patterson, SVP, Controllership at Gilead Sciences, reports the acquisition and disposal of common stock and restricted stock units on June 10, 2024.

Summary

• On June 10, 2024, Sandra Patterson, SVP, Controllership at Gilead Sciences, engaged in transactions involving the company's stock.
• Patterson acquired 901 shares of common stock through the vesting of restricted stock units.
• She also disposed of 255 shares of common stock at a price of $65.25.
• Following these transactions, Patterson directly owns 33,278 shares of Gilead Sciences common stock and 17,762 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral filing, simply reporting required insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies like Gilead Sciences. These filings are monitored by investors for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine insider trading activity.
• Shareholders may be interested in the filing as an indicator of management's actions regarding company stock.

Key Dates